+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Dysmenorrhea Treatment Market Research Report by Type, Treatment, Diagnosis, Mode of Prescription, Route of Administration, End-Users, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 245 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 5715746
UP TO OFF until Mar 31st 2023
The Global Dysmenorrhea Treatment Market size was estimated at USD 6,021.23 million in 2022, USD 6,615.52 million in 2023, and is projected to grow at a CAGR of 10.32% to reach USD 13,216.52 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Dysmenorrhea Treatment Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Dysmenorrhea Treatment Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Dysmenorrhea Treatment Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Dysmenorrhea Treatment Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Dysmenorrhea Treatment Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market is studied across Primary Dysmenorrhea and Secondary Dysmenorrhea.
  • Based on Treatment, the market is studied across Medication, Surgery, and Therapy.
  • Based on Diagnosis, the market is studied across CT Scan, Laparoscopy, Magnetic Resonance Imaging, and Ultrasound.
  • Based on Mode of Prescription, the market is studied across Over the Counter and Prescription.
  • Based on Route of Administration, the market is studied across Implants, Oral, and Parenteral.
  • Based on End-Users, the market is studied across Homecare, Hospitals, and Specialty Clinics.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Dysmenorrhea Treatment Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Dysmenorrhea Treatment Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Dysmenorrhea Treatment Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Dysmenorrhea Treatment Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Dysmenorrhea Treatment Market, including Abbott Laboratories, Alvogen, Bayer AG, Cora Life, F. Hoffmann-La Roche Ltd., Focus Consumer Healthcare, GlaxoSmithKline PLC, Merck KGaA, Novartis AG, Nua, Pfizer Inc., Reckitt Benckiser Group PLC, Sanofi, Taj Pharmaceuticals Limited, and Vanita's Rehab.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Dysmenorrhea Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Dysmenorrhea Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Dysmenorrhea Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Dysmenorrhea Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Dysmenorrhea Treatment Market?
6. What is the market share of the leading vendors in the Global Dysmenorrhea Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Dysmenorrhea Treatment Market?
Frequently Asked Questions about the Global Dysmenorrhea Treatment Market

What is the estimated value of the Global Dysmenorrhea Treatment Market?

The Global Dysmenorrhea Treatment Market was estimated to be valued at $6021.23 Million in 2022.

What is the growth rate of the Global Dysmenorrhea Treatment Market?

The growth rate of the Global Dysmenorrhea Treatment Market is 10.3%, with an estimated value of $13216.52 Million by 2030.

What is the forecasted size of the Global Dysmenorrhea Treatment Market?

The Global Dysmenorrhea Treatment Market is estimated to be worth $13216.52 Million by 2030.

Who are the key companies in the Global Dysmenorrhea Treatment Market?

Key companies in the Global Dysmenorrhea Treatment Market include Abbott Laboratories, Alvogen, Bayer AG, Cora Life, F. Hoffmann, La Roche Ltd., Focus Consumer Healthcare, GlaxoSmithKline PLC and Novartis AG.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of dysmenorrhea among adolescent girls
5.1.1.2. Increasing number of government measures to raise awareness
5.1.1.3. Growing geriatric population leads to use dysmenorrhea treatment
5.1.2. Restraints
5.1.2.1. Associated side effects and complications with dysmenorrhea treatment
5.1.3. Opportunities
5.1.3.1. Innovations in management of dysmenorrhea
5.1.3.2. Ongoing research and development activities
5.1.4. Challenges
5.1.4.1. Limited awareness about reproductive health in women
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Dysmenorrhea Treatment Market, by Type
6.1. Introduction
6.2. Primary Dysmenorrhea
6.3. Secondary Dysmenorrhea

7. Dysmenorrhea Treatment Market, by Treatment
7.1. Introduction
7.2. Medication
7.3. Surgery
7.4. Therapy

8. Dysmenorrhea Treatment Market, by Diagnosis
8.1. Introduction
8.2. CT Scan
8.3. Laparoscopy
8.4. Magnetic Resonance Imaging
8.5. Ultrasound

9. Dysmenorrhea Treatment Market, by Mode of Prescription
9.1. Introduction
9.2. Over the Counter
9.3. Prescription

10. Dysmenorrhea Treatment Market, by Route of Administration
10.1. Introduction
10.2. Implants
10.3. Oral
10.4. Parenteral

11. Dysmenorrhea Treatment Market, by End-Users
11.1. Introduction
11.2. Homecare
11.3. Hospitals
11.4. Specialty Clinics

12. Americas Dysmenorrhea Treatment Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States

13. Asia-Pacific Dysmenorrhea Treatment Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam

14. Europe, Middle East & Africa Dysmenorrhea Treatment Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis, By Key Player
15.3. Market Share Analysis, By Key Player
15.4. Product Portfolio Analysis, By Key Player
15.5. Competitive Scenario
15.5.1. Merger & Acquisition
15.5.2. Agreement, Collaboration, & Partnership
15.5.3. New Product Launch & Enhancement
15.5.4. Investment & Funding
15.5.5. Award, Recognition, & Expansion

16. Company Usability Profiles
16.1. Abbott Laboratories
16.2. Alvogen
16.3. Bayer AG
16.4. Cora Life
16.5. F. Hoffmann-La Roche Ltd.
16.6. Focus Consumer Healthcare
16.7. GlaxoSmithKline PLC
16.8. Merck KGaA
16.9. Novartis AG
16.10. Nua
16.11. Pfizer Inc.
16.12. Reckitt Benckiser Group PLC
16.13. Sanofi
16.14. Taj Pharmaceuticals Limited
16.15. Vanita's Rehab

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing


List of Figures
FIGURE 1. GLOBAL DYSMENORRHEA TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DYSMENORRHEA TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DYSMENORRHEA TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL DYSMENORRHEA TREATMENT MARKET DYNAMICS
FIGURE 11. GLOBAL DYSMENORRHEA TREATMENT MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 13. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL DYSMENORRHEA TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2030
FIGURE 15. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PRIMARY DYSMENORRHEA, 2018-2030 (USD MILLION)
FIGURE 16. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SECONDARY DYSMENORRHEA, 2018-2030 (USD MILLION)
FIGURE 17. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2022 VS 2030 (%)
FIGURE 18. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL DYSMENORRHEA TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY TREATMENT, 2030
FIGURE 20. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
FIGURE 21. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
FIGURE 22. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
FIGURE 23. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2022 VS 2030 (%)
FIGURE 24. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL DYSMENORRHEA TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY DIAGNOSIS, 2030
FIGURE 26. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY CT SCAN, 2018-2030 (USD MILLION)
FIGURE 27. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY LAPAROSCOPY, 2018-2030 (USD MILLION)
FIGURE 28. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING , 2018-2030 (USD MILLION)
FIGURE 29. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
FIGURE 30. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2022 VS 2030 (%)
FIGURE 31. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 32. GLOBAL DYSMENORRHEA TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY MODE OF PRESCRIPTION, 2030
FIGURE 33. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY OVER THE COUNTER, 2018-2030 (USD MILLION)
FIGURE 34. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
FIGURE 35. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
FIGURE 36. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 37. GLOBAL DYSMENORRHEA TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY ROUTE OF ADMINISTRATION, 2030
FIGURE 38. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
FIGURE 39. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
FIGURE 40. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
FIGURE 41. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2022 VS 2030 (%)
FIGURE 42. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 43. GLOBAL DYSMENORRHEA TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USERS, 2030
FIGURE 44. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
FIGURE 45. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
FIGURE 46. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
FIGURE 47. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 48. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 49. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 50. AMERICAS DYSMENORRHEA TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 51. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 52. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 53. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 54. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 55. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 56. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 57. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 58. UNITED STATES DYSMENORRHEA TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 59. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 61. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 62. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 63. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 64. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 65. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 66. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 67. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 68. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 69. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 70. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 71. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 72. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 73. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 74. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 75. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 76. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 77. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 78. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 79. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 80. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 81. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 82. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 83. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 84. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 85. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 86. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 87. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 88. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 89. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 90. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 91. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 92. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 93. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 94. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 95. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 96. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 97. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 98. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 99. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 100. GLOBAL DYSMENORRHEA TREATMENT MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 101. GLOBAL DYSMENORRHEA TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 102. GLOBAL DYSMENORRHEA TREATMENT MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL DYSMENORRHEA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PRIMARY DYSMENORRHEA, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PRIMARY DYSMENORRHEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PRIMARY DYSMENORRHEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SECONDARY DYSMENORRHEA, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SECONDARY DYSMENORRHEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SECONDARY DYSMENORRHEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY CT SCAN, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY CT SCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY CT SCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY LAPAROSCOPY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING , 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING , BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING , BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY OVER THE COUNTER, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY IMPLANTS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOMECARE, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 85. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 86. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 88. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 89. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 90. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 91. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 92. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 93. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 95. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 96. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 97. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 122. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 123. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 125. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 126. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 127. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 129. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 130. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 132. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 133. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 134. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 136. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 137. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 140. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 141. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 142. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 143. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 144. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 146. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 147. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 148. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 150. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 151. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 153. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 154. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 155. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 156. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 157. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 158. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 160. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 161. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 162. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 163. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 164. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 165. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 167. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 168. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 169. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 170. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 171. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 172. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 174. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 175. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 176. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 178. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 179. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 181. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 182. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 183. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 184. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 185. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 186. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 187. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 188. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 189. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 190. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 191. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 192. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 193. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 194. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 195. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 196. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 197. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 198. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 207. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 208. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 209. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 210. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 211. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 212. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 213. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 214. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 215. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 217. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 218. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 219. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 220. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 221. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 222. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 223. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 224. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 225. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 226. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 227. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 228. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 229. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 231. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 232. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 233. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 234. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 235. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 236. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 237. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 238. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 239. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 240. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 241. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 249. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 250. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 251. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 252. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 253. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 254. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 255. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 256. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 257. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 270. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 271. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 272. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 273. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 274. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 275. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 276. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 277. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 278. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 279. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 280. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 281. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 282. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 283. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 284. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 285. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 286. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 287. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 288. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 289. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 290. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 291. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 292. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 293. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 294. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 295. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 296. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 297. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 298. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 300. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 302. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 304. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 305. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 306. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 308. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 310. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 312. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 313. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 314. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 315. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 316. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 317. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 318. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 319. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 320. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 321. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 322. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 323. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 324. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 325. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 326. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 327. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 328. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 329. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 330. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 331. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 332. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 333. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 334. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 335. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 336. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 337. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 338. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 339. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 340. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 341. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 342. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 343. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE,

Companies Mentioned

  • Abbott Laboratories
  • Alvogen
  • Bayer AG
  • Cora Life
  • F. Hoffmann-La Roche Ltd.
  • Focus Consumer Healthcare
  • GlaxoSmithKline PLC
  • Merck KGaA
  • Novartis AG
  • Nua
  • Pfizer Inc.
  • Reckitt Benckiser Group PLC
  • Sanofi
  • Taj Pharmaceuticals Limited
  • Vanita's Rehab

Methodology

Loading
LOADING...